ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly 401(k) Notes receivable from participants (participant loans, $) ($)
Form 11-K Statements of Net Assets Available for Benefits
Latest, FY2025
30,484,221
Period ended Dec 31, 2025
Change on a year earlier
+6.0%
28,765,989 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | 401(k) Notes receivable from participants (participant loans, $) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30,484,221 | +6.0% | Form 11-K 2025 (filed 2026-06-23) ↗ |
| FY2024 | Dec 31, 2024 | 28,765,989 | +10.3% | Form 11-K 2024 (filed 2025-06-20) ↗ |
| FY2023 | Dec 31, 2023 | 26,081,722 | +16.3% | Form 11-K 2023 (filed 2024-06-24) ↗ |
| FY2022 | Dec 31, 2022 | 22,432,099 | +0.4% | Form 11-K 2022 (filed 2023-06-22) ↗ |
| FY2021 | Dec 31, 2021 | 22,350,660 | -4.4% | Form 11-K 2021 (filed 2022-06-27) ↗ |
| FY2020 | Dec 31, 2020 | 23,375,326 | -8.4% | Form 11-K 2020 (filed 2021-06-24) ↗ |
| FY2019 | Dec 31, 2019 | 25,524,186 | -12.2% | Form 11-K 2019 (filed 2020-06-16) ↗ |
| FY2018 | Dec 31, 2018 | 29,082,621 | -13.1% | Form 11-K 2018 (filed 2019-06-24) ↗ |
| FY2017 | Dec 31, 2017 | 33,464,590 | – | Form 11-K 2018 (filed 2019-06-24) ↗ |
Cite this data
StockData. (2026). Eli Lilly 401(k) Notes receivable from participants (participant loans, $) ($), annual FY2017–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/plan401k_notes_rec
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.